Enhance your practice with CME and tools that focus on diseases and conditions impacting the female patient.
Minimal By Design: Define MSE Endpoints
Christyn Edmundson, MD
Gil I. Wolfe MD, FAAN
The 2-Point Signal: Apply ≥2-Point Rule
The IgG Clock: Redose Using IgG Kinetics
Escalate With Intention: Stepwise, Target-Anchored Moves
Turning Flares Into Function: Flag Uncontrolled Disease
When to Begin FcRn: Initiation Criteria, Key Evidence
Primary Biliary Cholangitis: Shining Light on an "Invisible" Female Health Burden
Gideon Hirschfield, MB, BChir, PhD
Marlyn Mayo, MD
Diagnosing and Treating IBS: It Begins With One Simple Question
Brooks D. Cash, MD, AGAF, FACG, FACP, FASGE
Kimberly D. Orleck, PA-C
Treat. Target. Transform: Applying Treat-to-Target Principles in the Management of Generalized Myasthenia Gravis (gMG)
Scorecards That Matter: Use MG-ADL, MG-MMT, QMG, QoL
Shared Goals, Shared Gains: Align With Patient Preferences
Not Just a Headache: Migraine Across Women’s Lifespan
Jelena Pavlović, MD, PhD
Amaal J. Starling, MD, FAHS, FAAN
ENDOVOICE Live: Endometriosis—A Chronic Burden of Reproductive Years
Linda Bradley, MD
Obianuju Sandra Madueke-Laveaux, MD, MPH
Lauren R. Kornegay
Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT): Overcoming Diagnostic and Therapeutic Challenges
Karin J. Blakemore, MD
Emilie L. Vander Haar
Changing the Paradigm in the Management of Endometriosis: Moving Away From “Surgery First” to “Pharmacologic Therapy First”
Ayman Al-Hendy, MD, PhD, FRCSC, FACOG, CCRP
James A. Simon, MD, CCD, NCMP, IF, FACOG
The Integral Role of GnRH Antagonists in the Management of Endometriosis
Sawsan As-Sanie, MD
FcRn: Same Class, Different Paths—Spot Agent Differentiators
Target Locked in gMG: Why T2T Matters
Women’s Sleep Health – Addressing Gaps in OSA Diagnosis and Treatment Across Life Stages
Alison Kole, MD, MPH, FACCP
Ghada Bourjeily, MD, FCCP
Rashmi Nisha Aurora, MD
Audrey Wells, MD
Can We Talk? Optimizing Patient Buy-In to the Management of Endometriosis
Lee P. Shulman, MD, FACMG, FACOG
Cut to the Chase: Why Not Treat Endometriosis With GnRH Antagonists First?
Changing the Mindset in the Management of Endometriosis: Hitting the Pause Button on Surgical Procedures and Expanding the Role of GnRH Antagonists
Melissa Simon, MD
Samantha Denäe
Casey Joe Hinds
Why Are the Fetus and Placenta Not Rejected by the Mother? New Insights Into Maternal Anti-Fetal Rejection
Roberto Romero, MD, DMedSci
Parallels Between Kidney Transplantation and Maternal Anti-Fetal Rejection
Alexandra Benachi, MD, PhD
Julien Zuber, MD, PhD
The Alloimmune Disorders of Pregnancy: Optimizing Fetal Outcomes Through Advances in Diagnosis and Treatment
William Goodnight, MD, MSCR
Kara B. Markham, MD
The Alloimmune Disorders of Pregnancy
Early Diagnosis: Its Pivotal Role in Optimizing Outcomes in Patients With Endometriosis – Psychosocial and Physical Consequences
It’s Not Just Black and White: Seeing the Full Spectrum of Endometriosis Cases
Capturing the Impact of Endometriosis on Health-Related QoL: The Role of Patient Questionnaires
Alloimmune Neutropenia of the Fetus and Newborn
Masja de Haas, MD, PhD
Targeting the Fc Receptor Pathway to Treat Red Blood Cell Alloimmunization
Kenneth J. Moise Jr., MD
Unmasking Preeclampsia, the Great Masquerader
Mario R. Nacinovich, Jr., MSc
Kara Rood, MD
Loading...
We're glad to see you're enjoying Omnia Education… but how about a more personalized experience?
Press cancel to remain on Omnia Education. Press the link below or the continue button to keep going.